These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 18478051)
21. The lack of influence of food and local alcoholic brew on the blood level of Mectizan(®) (ivermectin). Homeida MM; Malcolm SB; ElTayeb AZ; Eversole RR; Elassad AS; Geary TG; Ali MM; Mackenzie CD Acta Trop; 2013 Aug; 127(2):97-100. PubMed ID: 23583861 [TBL] [Abstract][Full Text] [Related]
22. Extra-label use of ivermectin in some minor ruminant species: pharmacokinetic aspects. González-Canga A; Belmar-Liberato R; Escribano M Curr Pharm Biotechnol; 2012 May; 13(6):924-35. PubMed ID: 22039789 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic interaction between shuanghuanglian and azithromycin injection: a nonlinear mixed-effects model analysis in rats. Tian J; Sun S; Zhao Z; Li X Xenobiotica; 2019 Nov; 49(11):1344-1351. PubMed ID: 30457423 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs. Sarasola P; Jernigan AD; Walker DK; Castledine J; Smith DG; Rowan TG J Vet Pharmacol Ther; 2002 Aug; 25(4):265-72. PubMed ID: 12213114 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and bioequivalence in the pig of two ivermectin feed formulations. Lees P; Cheng Z; Chambers M; Speirs G; Hennessy D; Abbott EM J Vet Pharmacol Ther; 2013 Aug; 36(4):350-7. PubMed ID: 22882122 [TBL] [Abstract][Full Text] [Related]
26. Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. Guzzo CA; Furtek CI; Porras AG; Chen C; Tipping R; Clineschmidt CM; Sciberras DG; Hsieh JY; Lasseter KC J Clin Pharmacol; 2002 Oct; 42(10):1122-33. PubMed ID: 12362927 [TBL] [Abstract][Full Text] [Related]
27. Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and Adults. Brussee JM; Schulz JD; Coulibaly JT; Keiser J; Pfister M Clin Pharmacol Ther; 2019 Sep; 106(3):661-667. PubMed ID: 30993667 [TBL] [Abstract][Full Text] [Related]
28. Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration. Bassissi F; Lespine A; Alvinerie M Parasitol Res; 2006 Feb; 98(3):244-9. PubMed ID: 16341879 [TBL] [Abstract][Full Text] [Related]
29. A comparison of the efficacy and pharmacokinetics of ivermectin after spring and autumn treatments against Cyathostominae in horses. Sokół R; Raś-Noryńska M; Michalczyk M; Jasiecka A; Ziółkowski H; Jaroszewski J Pol J Vet Sci; 2015; 18(2):371-7. PubMed ID: 26172188 [TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy assessment of the albendazole-ivermectin combination in lambs parasitized with resistant nematodes. Entrocasso C; Alvarez L; Manazza J; Lifschitz A; Borda B; Virkel G; Mottier L; Lanusse C Vet Parasitol; 2008 Aug; 155(3-4):249-56. PubMed ID: 18571329 [TBL] [Abstract][Full Text] [Related]
31. Formulation Studies of Solid Self-Emulsifying Drug Delivery System of Ivermectin. Patel VP; Lakkad HA; Ashara KC Folia Med (Plovdiv); 2018 Dec; 60(4):580-593. PubMed ID: 31188767 [TBL] [Abstract][Full Text] [Related]
32. Multiple oral dosing of ketoconazole increases dog exposure to ivermectin. Hugnet C; Lespine A; Alvinerie M J Pharm Pharm Sci; 2007; 10(3):311-8. PubMed ID: 17727794 [TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin. Chandra R; Liu P; Breen JD; Fisher J; Xie C; LaBadie R; Benner RJ; Benincosa LJ; Sharma A Clin Pharmacokinet; 2007; 46(3):247-59. PubMed ID: 17328583 [TBL] [Abstract][Full Text] [Related]
34. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus. Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872 [TBL] [Abstract][Full Text] [Related]
35. Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing. Jermain B; Hanafin PO; Cao Y; Lifschitz A; Lanusse C; Rao GG J Pharm Sci; 2020 Dec; 109(12):3574-3578. PubMed ID: 32891630 [TBL] [Abstract][Full Text] [Related]
36. The pharmacokinetics and interactions of ivermectin in humans--a mini-review. González Canga A; Sahagún Prieto AM; Diez Liébana MJ; Fernández Martínez N; Sierra Vega M; García Vieitez JJ AAPS J; 2008; 10(1):42-6. PubMed ID: 18446504 [TBL] [Abstract][Full Text] [Related]
37. The pharmacokinetics and antiparasitic activity of ivermectin in Hutsul and Toric horses. Vyniarska A; Ziółkowski H; Madej-Śmiechowska H; Jaroszewski JJ J Vet Pharmacol Ther; 2021 Jan; 44(1):11-17. PubMed ID: 33103252 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of extended-release ivermectin microspheres after oral administration to healthy pigs. Xu Y; Zhang S; Qiu Y; Yu Y; Zhang Y; Huang X J Vet Pharmacol Ther; 2020 Sep; 43(5):485-490. PubMed ID: 32304335 [TBL] [Abstract][Full Text] [Related]
39. The pharmacokinetics and metabolism of ivermectin in domestic animal species. González Canga A; Sahagún Prieto AM; José Diez Liébana M; Martínez NF; Vega MS; Vieitez JJ Vet J; 2009 Jan; 179(1):25-37. PubMed ID: 17851096 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic interaction of Forsythia suspensa extract and azithromycin injection after single and co-intravenous administration in rats. Li XG; Ni J; Shen S; Wang XP; Tian JC Chin J Nat Med; 2020 Mar; 18(3):234-240. PubMed ID: 32245594 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]